サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1757181

未分画ヘパリンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

Global Unfractionated Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

出版日
発行
QYResearch
ページ情報
英文 108 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
未分画ヘパリンの世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)
出版日: 2025年06月27日
発行: QYResearch
ページ情報: 英文 108 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、未分画ヘパリン (Unfractionated Heparin) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場の事業概要

  • 未分画ヘパリン 製品範囲
  • 未分画ヘパリン タイプ別
    • 世界の未分画ヘパリン 販売：タイプ別 (2020 & 2024 & 2031)
    • Heparin Sodium
    • Heparin Calcium
  • 未分画ヘパリン 用途別
    • 世界の未分画ヘパリン 売上 比較：用途別 (2020 & 2024 & 2031)
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Myocardial Infarction
    • Unstable Angina
    • Atrial Fibrillation-related Clots
    • Other
  • 世界の未分画ヘパリン 市場 推定および予測 (2020-2031)
    • 世界の未分画ヘパリン 市場規模 in 価格 成長率 (2020-2031)
    • Global Unfractionated Heparin Market Size in Volume Growth Rate (2020-2031)
    • Global Unfractionated Heparin Price Trends (2020-2031)
  • 前提条件と制限

第2章 市場規模と予測：地域別

  • 世界の未分画ヘパリン 市場規模：地域別: 2020 VS 2024 VS 2031
  • 世界の未分画ヘパリン 過去の市場分析：地域別 (2020-2025)
    • 世界の未分画ヘパリンの販売市場シェア 地域別 (2020-2025)
    • 世界の未分画ヘパリンの収益市場シェア 地域別 (2020-2025)
  • 世界の未分画ヘパリン 市場 推定および予測 地域別 (2026-2031)
    • 世界の未分画ヘパリン 売上予測・予想 地域別 (2026-2031)
    • 世界の未分画ヘパリンの収益予測：地域別 (2026-2031)
  • 主要地域と新興市場分析
    • 北米の未分画ヘパリン 市場規模および予測 (2020-2031)
    • 欧州の未分画ヘパリン 市場規模および予測 (2020-2031)
    • 中国の未分画ヘパリン 市場規模および予測 (2020-2031)
    • 日本の未分画ヘパリン 市場規模および予測 (2020-2031)
    • インド 未分画ヘパリン 市場規模および予測 (2020-2031)

第3章 世界の市場規模：タイプ別

  • 世界の未分画ヘパリンの過去の市場概要：タイプ別 (2020-2025)
    • 世界の未分画ヘパリン 販売：タイプ別 (2020-2025)
    • 世界の未分画ヘパリン 収益：タイプ別 (2020-2025)
    • 世界の未分画ヘパリン 価格：タイプ別 (2020-2025)
  • 世界の未分画ヘパリンの市場 推定および予測：タイプ別 (2026-2031)
    • 世界の未分画ヘパリンの販売予測：タイプ別 (2026-2031)
    • 世界の未分画ヘパリンの収益予測：タイプ別 (2026-2031)
    • 世界の未分画ヘパリンの価格予測：タイプ別 (2026-2031)
  • 各種タイプ 未分画ヘパリン 代表的な企業

第4章 世界の市場規模：用途別

  • 世界の未分画ヘパリンの過去の市場概要：用途別 (2020-2025)
    • 世界の未分画ヘパリン 販売：用途別 (2020-2025)
    • 世界の未分画ヘパリン 収益：用途別 (2020-2025)
    • 世界の未分画ヘパリン 価格：用途別 (2020-2025)
  • 世界の未分画ヘパリン 市場 推定および予測：用途別 (2026-2031)
    • 世界の未分画ヘパリンの販売予測：用途別 (2026-2031)
    • 世界の未分画ヘパリンの収益予測：用途別 (2026-2031)
    • 世界の未分画ヘパリンの価格予測：用途別 (2026-2031)
  • 新たな成長源 未分画ヘパリン アプリケーション

第5章 競合他社の状況

  • 世界の未分画ヘパリン 売上 ：競合別 (2020-2025)
  • 世界の未分画ヘパリンの上位企業：収益別 (2020-2025)
  • 世界の未分画ヘパリンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3) & (収益ベース 未分画ヘパリン 2024年)
  • 世界の未分画ヘパリン 企業別平均価格 (2020-2025)
  • 世界の主要メーカー 未分画ヘパリン, 製造拠点 & 本社
  • 世界の主要メーカー 未分画ヘパリン, 製品の種類・用途
  • 世界の主要メーカー 未分画ヘパリン, 業界参入時期
  • 企業のM&A, 拡張計画

第6章 地域分析

  • 北米の市場: 参入企業、セグメント、下流、主要顧客
    • 北米の未分画ヘパリン 売上：企業別
    • 北米の未分画ヘパリン 売上 内訳 タイプ別 (2020-2025)
    • 北米の未分画ヘパリン 売上構成比：用途別 (2020-2025)
    • 北米の未分画ヘパリン 主要顧客
    • 北米の市場 トレンドと機会
  • 欧州の市場: 参入企業、セグメント、下流、主要顧客
    • 欧州の未分画ヘパリン 売上：企業別
    • 欧州の未分画ヘパリン 売上 内訳 タイプ別 (2020-2025)
    • 欧州の未分画ヘパリン 売上構成比：用途別 (2020-2025)
    • 欧州の未分画ヘパリン 主要顧客
    • 欧州の市場 トレンドと機会
  • 中国の市場: 参入企業、セグメント、下流、主要顧客
    • 中国の未分画ヘパリン 売上：企業別
    • 中国の未分画ヘパリン 売上 内訳 タイプ別 (2020-2025)
    • 中国の未分画ヘパリン 売上構成比：用途別 (2020-2025)
    • 中国の未分画ヘパリン 主要顧客
    • 中国の市場 トレンドと機会
  • 日本の市場: 参入企業、セグメント、下流、主要顧客
    • 日本の未分画ヘパリン 売上：企業別
    • 日本の未分画ヘパリン 売上 内訳 タイプ別 (2020-2025)
    • 日本の未分画ヘパリン 売上構成比：用途別 (2020-2025)
    • 日本の未分画ヘパリン 主要顧客
    • 日本の市場 トレンドと機会
  • インド 市場: 参入企業、セグメント、下流、主要顧客
    • インド 未分画ヘパリン 売上：企業別
    • インド 未分画ヘパリン 売上 内訳 タイプ別 (2020-2025)
    • インド 未分画ヘパリン 売上構成比：用途別 (2020-2025)
    • インド 未分画ヘパリン 主要顧客
    • インド 市場 トレンドと機会

第7章 企業概要と主要企業

  • Sanofi
  • Pfizer
  • Organon Canada
  • Leo Pharma
  • Panpharma
  • Rotexmedica GmbH
  • Bharat Serums and Vaccines
  • Troikaa Pharmaceuticals
  • Wellona Pharma
  • B. Braun
  • Bioiberica
  • Sagent Pharmaceuticals, Inc
  • Gland Pharma Limited
  • Stanex
  • Mylan
  • Rewine Pharmaceutical
  • Jianyou Pharmaceutical
  • Shenzhen Techdow Pharmaceutical
  • Changshan Pharma
  • Dongcheng Pharmaceutical

第8章 未分画ヘパリン 製造コスト分析

  • 未分画ヘパリン 主要原材料の分析
    • 主要原材料
    • 原材料の主な調達先
  • 製造コスト構成比
  • 製造工程分析： 未分画ヘパリン
  • 未分画ヘパリン 産業チェーン分析

第9章 マーケティングチャネル, 販売店と顧客

  • マーケティングチャネル
  • 未分画ヘパリン 販売代理店一覧
  • 未分画ヘパリン 顧客

第10章 未分画ヘパリン 市場動向

  • 未分画ヘパリン 業界動向
  • 未分画ヘパリン 市場の促進要因
  • 未分画ヘパリン 市場の課題
  • 未分画ヘパリン 市場の抑制要因

第11章 市場調査結果と結論

第12章 付録

図表

List of Tables

Table 1. Global Unfractionated Heparin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Unfractionated Heparin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Unfractionated Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Unfractionated Heparin Sales (K Dose) by Region (2020-2025)

Table 5. Global Unfractionated Heparin Sales Market Share by Region (2020-2025)

Table 6. Global Unfractionated Heparin Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Unfractionated Heparin Revenue Share by Region (2020-2025)

Table 8. Global Unfractionated Heparin Sales (K Dose) Forecast by Region (2026-2031)

Table 9. Global Unfractionated Heparin Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Unfractionated Heparin Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Unfractionated Heparin Revenue Share Forecast by Region (2026-2031)

Table 12. Global Unfractionated Heparin Sales by Type (K Dose) & (2020-2025)

Table 13. Global Unfractionated Heparin Sales Share by Type (2020-2025)

Table 14. Global Unfractionated Heparin Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Unfractionated Heparin Price by Type (US$/Dose) & (2020-2025)

Table 16. Global Unfractionated Heparin Sales by Type (K Dose) & (2026-2031)

Table 17. Global Unfractionated Heparin Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Unfractionated Heparin Price by Type (US$/Dose) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Unfractionated Heparin Sales by Application (K Dose) & (2020-2025)

Table 21. Global Unfractionated Heparin Sales Share by Application (2020-2025)

Table 22. Global Unfractionated Heparin Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Unfractionated Heparin Price by Application (US$/Dose) & (2020-2025)

Table 24. Global Unfractionated Heparin Sales by Application (K Dose) & (2026-2031)

Table 25. Global Unfractionated Heparin Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Unfractionated Heparin Price by Application (US$/Dose) & (2026-2031)

Table 27. New Sources of Growth in Unfractionated Heparin Application

Table 28. Global Unfractionated Heparin Sales by Company (K Dose) & (2020-2025)

Table 29. Global Unfractionated Heparin Sales Share by Company (2020-2025)

Table 30. Global Unfractionated Heparin Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Unfractionated Heparin Revenue Share by Company (2020-2025)

Table 32. Global Unfractionated Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Unfractionated Heparin as of 2024)

Table 33. Global Market Unfractionated Heparin Average Price by Company (US$/Dose) & (2020-2025)

Table 34. Global Key Manufacturers of Unfractionated Heparin, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Unfractionated Heparin, Product Type & Application

Table 36. Global Key Manufacturers of Unfractionated Heparin, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Unfractionated Heparin Sales by Company (2020-2025) & (K Dose)

Table 39. North America Unfractionated Heparin Sales Market Share by Company (2020-2025)

Table 40. North America Unfractionated Heparin Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Unfractionated Heparin Revenue Market Share by Company (2020-2025)

Table 42. North America Unfractionated Heparin Sales by Type (2020-2025) & (K Dose)

Table 43. North America Unfractionated Heparin Sales Market Share by Type (2020-2025)

Table 44. North America Unfractionated Heparin Sales by Application (2020-2025) & (K Dose)

Table 45. North America Unfractionated Heparin Sales Market Share by Application (2020-2025)

Table 46. Europe Unfractionated Heparin Sales by Company (2020-2025) & (K Dose)

Table 47. Europe Unfractionated Heparin Sales Market Share by Company (2020-2025)

Table 48. Europe Unfractionated Heparin Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Unfractionated Heparin Revenue Market Share by Company (2020-2025)

Table 50. Europe Unfractionated Heparin Sales by Type (2020-2025) & (K Dose)

Table 51. Europe Unfractionated Heparin Sales Market Share by Type (2020-2025)

Table 52. Europe Unfractionated Heparin Sales by Application (2020-2025) & (K Dose)

Table 53. Europe Unfractionated Heparin Sales Market Share by Application (2020-2025)

Table 54. China Unfractionated Heparin Sales by Company (2020-2025) & (K Dose)

Table 55. China Unfractionated Heparin Sales Market Share by Company (2020-2025)

Table 56. China Unfractionated Heparin Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Unfractionated Heparin Revenue Market Share by Company (2020-2025)

Table 58. China Unfractionated Heparin Sales by Type (2020-2025) & (K Dose)

Table 59. China Unfractionated Heparin Sales Market Share by Type (2020-2025)

Table 60. China Unfractionated Heparin Sales by Application (2020-2025) & (K Dose)

Table 61. China Unfractionated Heparin Sales Market Share by Application (2020-2025)

Table 62. Japan Unfractionated Heparin Sales by Company (2020-2025) & (K Dose)

Table 63. Japan Unfractionated Heparin Sales Market Share by Company (2020-2025)

Table 64. Japan Unfractionated Heparin Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Unfractionated Heparin Revenue Market Share by Company (2020-2025)

Table 66. Japan Unfractionated Heparin Sales by Type (2020-2025) & (K Dose)

Table 67. Japan Unfractionated Heparin Sales Market Share by Type (2020-2025)

Table 68. Japan Unfractionated Heparin Sales by Application (2020-2025) & (K Dose)

Table 69. Japan Unfractionated Heparin Sales Market Share by Application (2020-2025)

Table 70. India Unfractionated Heparin Sales by Company (2020-2025) & (K Dose)

Table 71. India Unfractionated Heparin Sales Market Share by Company (2020-2025)

Table 72. India Unfractionated Heparin Revenue by Company (2020-2025) & (US$ Million)

Table 73. India Unfractionated Heparin Revenue Market Share by Company (2020-2025)

Table 74. India Unfractionated Heparin Sales by Type (2020-2025) & (K Dose)

Table 75. India Unfractionated Heparin Sales Market Share by Type (2020-2025)

Table 76. India Unfractionated Heparin Sales by Application (2020-2025) & (K Dose)

Table 77. India Unfractionated Heparin Sales Market Share by Application (2020-2025)

Table 78. Sanofi Company Information

Table 79. Sanofi Description and Business Overview

Table 80. Sanofi Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 81. Sanofi Unfractionated Heparin Product

Table 82. Sanofi Recent Development

Table 83. Pfizer Company Information

Table 84. Pfizer Description and Business Overview

Table 85. Pfizer Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 86. Pfizer Unfractionated Heparin Product

Table 87. Pfizer Recent Development

Table 88. Organon Canada Company Information

Table 89. Organon Canada Description and Business Overview

Table 90. Organon Canada Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 91. Organon Canada Unfractionated Heparin Product

Table 92. Organon Canada Recent Development

Table 93. Leo Pharma Company Information

Table 94. Leo Pharma Description and Business Overview

Table 95. Leo Pharma Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 96. Leo Pharma Unfractionated Heparin Product

Table 97. Leo Pharma Recent Development

Table 98. Panpharma Company Information

Table 99. Panpharma Description and Business Overview

Table 100. Panpharma Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 101. Panpharma Unfractionated Heparin Product

Table 102. Panpharma Recent Development

Table 103. Rotexmedica GmbH Company Information

Table 104. Rotexmedica GmbH Description and Business Overview

Table 105. Rotexmedica GmbH Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 106. Rotexmedica GmbH Unfractionated Heparin Product

Table 107. Rotexmedica GmbH Recent Development

Table 108. Bharat Serums and Vaccines Company Information

Table 109. Bharat Serums and Vaccines Description and Business Overview

Table 110. Bharat Serums and Vaccines Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 111. Bharat Serums and Vaccines Unfractionated Heparin Product

Table 112. Bharat Serums and Vaccines Recent Development

Table 113. Troikaa Pharmaceuticals Company Information

Table 114. Troikaa Pharmaceuticals Description and Business Overview

Table 115. Troikaa Pharmaceuticals Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 116. Troikaa Pharmaceuticals Unfractionated Heparin Product

Table 117. Troikaa Pharmaceuticals Recent Development

Table 118. Wellona Pharma Company Information

Table 119. Wellona Pharma Description and Business Overview

Table 120. Wellona Pharma Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 121. Wellona Pharma Unfractionated Heparin Product

Table 122. Wellona Pharma Recent Development

Table 123. B. Braun Company Information

Table 124. B. Braun Description and Business Overview

Table 125. B. Braun Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 126. B. Braun Unfractionated Heparin Product

Table 127. B. Braun Recent Development

Table 128. Bioiberica Company Information

Table 129. Bioiberica Description and Business Overview

Table 130. Bioiberica Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 131. Bioiberica Unfractionated Heparin Product

Table 132. Bioiberica Recent Development

Table 133. Sagent Pharmaceuticals, Inc Company Information

Table 134. Sagent Pharmaceuticals, Inc Description and Business Overview

Table 135. Sagent Pharmaceuticals, Inc Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 136. Sagent Pharmaceuticals, Inc Unfractionated Heparin Product

Table 137. Sagent Pharmaceuticals, Inc Recent Development

Table 138. Gland Pharma Limited Company Information

Table 139. Gland Pharma Limited Description and Business Overview

Table 140. Gland Pharma Limited Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 141. Gland Pharma Limited Unfractionated Heparin Product

Table 142. Gland Pharma Limited Recent Development

Table 143. Stanex Company Information

Table 144. Stanex Description and Business Overview

Table 145. Stanex Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 146. Stanex Unfractionated Heparin Product

Table 147. Stanex Recent Development

Table 148. Mylan Company Information

Table 149. Mylan Description and Business Overview

Table 150. Mylan Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 151. Mylan Unfractionated Heparin Product

Table 152. Mylan Recent Development

Table 153. Rewine Pharmaceutical Company Information

Table 154. Rewine Pharmaceutical Description and Business Overview

Table 155. Rewine Pharmaceutical Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 156. Rewine Pharmaceutical Unfractionated Heparin Product

Table 157. Rewine Pharmaceutical Recent Development

Table 158. Jianyou Pharmaceutical Company Information

Table 159. Jianyou Pharmaceutical Description and Business Overview

Table 160. Jianyou Pharmaceutical Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 161. Jianyou Pharmaceutical Unfractionated Heparin Product

Table 162. Jianyou Pharmaceutical Recent Development

Table 163. Shenzhen Techdow Pharmaceutical Company Information

Table 164. Shenzhen Techdow Pharmaceutical Description and Business Overview

Table 165. Shenzhen Techdow Pharmaceutical Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 166. Shenzhen Techdow Pharmaceutical Unfractionated Heparin Product

Table 167. Shenzhen Techdow Pharmaceutical Recent Development

Table 168. Changshan Pharma Company Information

Table 169. Changshan Pharma Description and Business Overview

Table 170. Changshan Pharma Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 171. Changshan Pharma Unfractionated Heparin Product

Table 172. Changshan Pharma Recent Development

Table 173. Dongcheng Pharmaceutical Company Information

Table 174. Dongcheng Pharmaceutical Description and Business Overview

Table 175. Dongcheng Pharmaceutical Unfractionated Heparin Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 176. Dongcheng Pharmaceutical Unfractionated Heparin Product

Table 177. Dongcheng Pharmaceutical Recent Development

Table 178. Production Base and Market Concentration Rate of Raw Material

Table 179. Key Suppliers of Raw Materials

Table 180. Unfractionated Heparin Distributors List

Table 181. Unfractionated Heparin Customers List

Table 182. Unfractionated Heparin Market Trends

Table 183. Unfractionated Heparin Market Drivers

Table 184. Unfractionated Heparin Market Challenges

Table 185. Unfractionated Heparin Market Restraints

Table 186. Research Programs/Design for This Report

Table 187. Key Data Information from Secondary Sources

Table 188. Key Data Information from Primary Sources

List of Figures

Figure 1. Unfractionated Heparin Product Picture

Figure 2. Global Unfractionated Heparin Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Unfractionated Heparin Sales Market Share by Type in 2024 & 2031

Figure 4. Heparin Sodium Product Picture

Figure 5. Heparin Calcium Product Picture

Figure 6. Global Unfractionated Heparin Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Unfractionated Heparin Sales Market Share by Application in 2024 & 2031

Figure 8. Deep Vein Thrombosis (DVT) Examples

Figure 9. Pulmonary Embolism (PE) Examples

Figure 10. Myocardial Infarction Examples

Figure 11. Unstable Angina Examples

Figure 12. Atrial Fibrillation-related Clots Examples

Figure 13. Other Examples

Figure 14. Global Unfractionated Heparin Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Unfractionated Heparin Sales Growth Rate (2020-2031) & (US$ Million)

Figure 16. Global Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 17. Global Unfractionated Heparin Price Trends Growth Rate (2020-2031) & (US$/Dose)

Figure 18. Unfractionated Heparin Report Years Considered

Figure 19. Global Market Unfractionated Heparin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 20. Global Unfractionated Heparin Revenue Market Share by Region: 2020 VS 2024

Figure 21. North America Unfractionated Heparin Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. North America Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 23. Europe Unfractionated Heparin Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Europe Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 25. China Unfractionated Heparin Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. China Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 27. Japan Unfractionated Heparin Revenue (US$ Million) Growth Rate (2020-2031)

Figure 28. Japan Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 29. India Unfractionated Heparin Revenue (US$ Million) Growth Rate (2020-2031)

Figure 30. India Unfractionated Heparin Sales (K Dose) Growth Rate (2020-2031)

Figure 31. Global Unfractionated Heparin Revenue Share by Type (2020-2025)

Figure 32. Global Unfractionated Heparin Sales Share by Type (2026-2031)

Figure 33. Global Unfractionated Heparin Revenue Share by Type (2026-2031)

Figure 34. Global Unfractionated Heparin Revenue Share by Application (2020-2025)

Figure 35. Global Unfractionated Heparin Revenue Growth Rate by Application in 2020 & 2024

Figure 36. Global Unfractionated Heparin Sales Share by Application (2026-2031)

Figure 37. Global Unfractionated Heparin Revenue Share by Application (2026-2031)

Figure 38. Global Unfractionated Heparin Sales Share by Company (2024)

Figure 39. Global Unfractionated Heparin Revenue Share by Company (2024)

Figure 40. Global 5 Largest Unfractionated Heparin Players Market Share by Revenue in Unfractionated Heparin: 2020 & 2024

Figure 41. Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 42. Manufacturing Cost Structure of Unfractionated Heparin

Figure 43. Manufacturing Process Analysis of Unfractionated Heparin

Figure 44. Unfractionated Heparin Industrial Chain

Figure 45. Channels of Distribution (Direct Vs Distribution)

Figure 46. Distributors Profiles

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

目次

This research report focuses on the Unfractionated Heparin Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Unfractionated Heparin Product Scope
  • 1.2 Unfractionated Heparin by Type
    • 1.2.1 Global Unfractionated Heparin Sales by Type (2020 & 2024 & 2031)
    • 1.2.2 Heparin Sodium
    • 1.2.3 Heparin Calcium
  • 1.3 Unfractionated Heparin by Application
    • 1.3.1 Global Unfractionated Heparin Sales Comparison by Application (2020 & 2024 & 2031)
    • 1.3.2 Deep Vein Thrombosis (DVT)
    • 1.3.3 Pulmonary Embolism (PE)
    • 1.3.4 Myocardial Infarction
    • 1.3.5 Unstable Angina
    • 1.3.6 Atrial Fibrillation-related Clots
    • 1.3.7 Other
  • 1.4 Global Unfractionated Heparin Market Estimates and Forecasts (2020-2031)
    • 1.4.1 Global Unfractionated Heparin Market Size in Value Growth Rate (2020-2031)
    • 1.4.2 Global Unfractionated Heparin Market Size in Volume Growth Rate (2020-2031)
    • 1.4.3 Global Unfractionated Heparin Price Trends (2020-2031)
  • 1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

  • 2.1 Global Unfractionated Heparin Market Size by Region: 2020 VS 2024 VS 2031
  • 2.2 Global Unfractionated Heparin Retrospective Market Scenario by Region (2020-2025)
    • 2.2.1 Global Unfractionated Heparin Sales Market Share by Region (2020-2025)
    • 2.2.2 Global Unfractionated Heparin Revenue Market Share by Region (2020-2025)
  • 2.3 Global Unfractionated Heparin Market Estimates and Forecasts by Region (2026-2031)
    • 2.3.1 Global Unfractionated Heparin Sales Estimates and Forecasts by Region (2026-2031)
    • 2.3.2 Global Unfractionated Heparin Revenue Forecast by Region (2026-2031)
  • 2.4 Major Region and Emerging Market Analysis
    • 2.4.1 North America Unfractionated Heparin Market Size and Prospective (2020-2031)
    • 2.4.2 Europe Unfractionated Heparin Market Size and Prospective (2020-2031)
    • 2.4.3 China Unfractionated Heparin Market Size and Prospective (2020-2031)
    • 2.4.4 Japan Unfractionated Heparin Market Size and Prospective (2020-2031)
    • 2.4.5 India Unfractionated Heparin Market Size and Prospective (2020-2031)

3 Global Market Size by Type

  • 3.1 Global Unfractionated Heparin Historic Market Review by Type (2020-2025)
    • 3.1.1 Global Unfractionated Heparin Sales by Type (2020-2025)
    • 3.1.2 Global Unfractionated Heparin Revenue by Type (2020-2025)
    • 3.1.3 Global Unfractionated Heparin Price by Type (2020-2025)
  • 3.2 Global Unfractionated Heparin Market Estimates and Forecasts by Type (2026-2031)
    • 3.2.1 Global Unfractionated Heparin Sales Forecast by Type (2026-2031)
    • 3.2.2 Global Unfractionated Heparin Revenue Forecast by Type (2026-2031)
    • 3.2.3 Global Unfractionated Heparin Price Forecast by Type (2026-2031)
  • 3.3 Different Types Unfractionated Heparin Representative Players

4 Global Market Size by Application

  • 4.1 Global Unfractionated Heparin Historic Market Review by Application (2020-2025)
    • 4.1.1 Global Unfractionated Heparin Sales by Application (2020-2025)
    • 4.1.2 Global Unfractionated Heparin Revenue by Application (2020-2025)
    • 4.1.3 Global Unfractionated Heparin Price by Application (2020-2025)
  • 4.2 Global Unfractionated Heparin Market Estimates and Forecasts by Application (2026-2031)
    • 4.2.1 Global Unfractionated Heparin Sales Forecast by Application (2026-2031)
    • 4.2.2 Global Unfractionated Heparin Revenue Forecast by Application (2026-2031)
    • 4.2.3 Global Unfractionated Heparin Price Forecast by Application (2026-2031)
  • 4.3 New Sources of Growth in Unfractionated Heparin Application

5 Competition Landscape by Players

  • 5.1 Global Unfractionated Heparin Sales by Players (2020-2025)
  • 5.2 Global Top Unfractionated Heparin Players by Revenue (2020-2025)
  • 5.3 Global Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Unfractionated Heparin as of 2024)
  • 5.4 Global Unfractionated Heparin Average Price by Company (2020-2025)
  • 5.5 Global Key Manufacturers of Unfractionated Heparin, Manufacturing Sites & Headquarters
  • 5.6 Global Key Manufacturers of Unfractionated Heparin, Product Type & Application
  • 5.7 Global Key Manufacturers of Unfractionated Heparin, Date of Enter into This Industry
  • 5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

  • 6.1 North America Market: Players, Segments, Downstream and Major Customers
    • 6.1.1 North America Unfractionated Heparin Sales by Company
      • 6.1.1.1 North America Unfractionated Heparin Sales by Company (2020-2025)
      • 6.1.1.2 North America Unfractionated Heparin Revenue by Company (2020-2025)
    • 6.1.2 North America Unfractionated Heparin Sales Breakdown by Type (2020-2025)
    • 6.1.3 North America Unfractionated Heparin Sales Breakdown by Application (2020-2025)
    • 6.1.4 North America Unfractionated Heparin Major Customer
    • 6.1.5 North America Market Trend and Opportunities
  • 6.2 Europe Market: Players, Segments, Downstream and Major Customers
    • 6.2.1 Europe Unfractionated Heparin Sales by Company
      • 6.2.1.1 Europe Unfractionated Heparin Sales by Company (2020-2025)
      • 6.2.1.2 Europe Unfractionated Heparin Revenue by Company (2020-2025)
    • 6.2.2 Europe Unfractionated Heparin Sales Breakdown by Type (2020-2025)
    • 6.2.3 Europe Unfractionated Heparin Sales Breakdown by Application (2020-2025)
    • 6.2.4 Europe Unfractionated Heparin Major Customer
    • 6.2.5 Europe Market Trend and Opportunities
  • 6.3 China Market: Players, Segments, Downstream and Major Customers
    • 6.3.1 China Unfractionated Heparin Sales by Company
      • 6.3.1.1 China Unfractionated Heparin Sales by Company (2020-2025)
      • 6.3.1.2 China Unfractionated Heparin Revenue by Company (2020-2025)
    • 6.3.2 China Unfractionated Heparin Sales Breakdown by Type (2020-2025)
    • 6.3.3 China Unfractionated Heparin Sales Breakdown by Application (2020-2025)
    • 6.3.4 China Unfractionated Heparin Major Customer
    • 6.3.5 China Market Trend and Opportunities
  • 6.4 Japan Market: Players, Segments, Downstream and Major Customers
    • 6.4.1 Japan Unfractionated Heparin Sales by Company
      • 6.4.1.1 Japan Unfractionated Heparin Sales by Company (2020-2025)
      • 6.4.1.2 Japan Unfractionated Heparin Revenue by Company (2020-2025)
    • 6.4.2 Japan Unfractionated Heparin Sales Breakdown by Type (2020-2025)
    • 6.4.3 Japan Unfractionated Heparin Sales Breakdown by Application (2020-2025)
    • 6.4.4 Japan Unfractionated Heparin Major Customer
    • 6.4.5 Japan Market Trend and Opportunities
  • 6.5 India Market: Players, Segments, Downstream and Major Customers
    • 6.5.1 India Unfractionated Heparin Sales by Company
      • 6.5.1.1 India Unfractionated Heparin Sales by Company (2020-2025)
      • 6.5.1.2 India Unfractionated Heparin Revenue by Company (2020-2025)
    • 6.5.2 India Unfractionated Heparin Sales Breakdown by Type (2020-2025)
    • 6.5.3 India Unfractionated Heparin Sales Breakdown by Application (2020-2025)
    • 6.5.4 India Unfractionated Heparin Major Customer
    • 6.5.5 India Market Trend and Opportunities

7 Company Profiles and Key Figures

  • 7.1 Sanofi
    • 7.1.1 Sanofi Company Information
    • 7.1.2 Sanofi Business Overview
    • 7.1.3 Sanofi Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.1.4 Sanofi Unfractionated Heparin Products Offered
    • 7.1.5 Sanofi Recent Development
  • 7.2 Pfizer
    • 7.2.1 Pfizer Company Information
    • 7.2.2 Pfizer Business Overview
    • 7.2.3 Pfizer Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.2.4 Pfizer Unfractionated Heparin Products Offered
    • 7.2.5 Pfizer Recent Development
  • 7.3 Organon Canada
    • 7.3.1 Organon Canada Company Information
    • 7.3.2 Organon Canada Business Overview
    • 7.3.3 Organon Canada Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.3.4 Organon Canada Unfractionated Heparin Products Offered
    • 7.3.5 Organon Canada Recent Development
  • 7.4 Leo Pharma
    • 7.4.1 Leo Pharma Company Information
    • 7.4.2 Leo Pharma Business Overview
    • 7.4.3 Leo Pharma Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.4.4 Leo Pharma Unfractionated Heparin Products Offered
    • 7.4.5 Leo Pharma Recent Development
  • 7.5 Panpharma
    • 7.5.1 Panpharma Company Information
    • 7.5.2 Panpharma Business Overview
    • 7.5.3 Panpharma Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.5.4 Panpharma Unfractionated Heparin Products Offered
    • 7.5.5 Panpharma Recent Development
  • 7.6 Rotexmedica GmbH
    • 7.6.1 Rotexmedica GmbH Company Information
    • 7.6.2 Rotexmedica GmbH Business Overview
    • 7.6.3 Rotexmedica GmbH Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.6.4 Rotexmedica GmbH Unfractionated Heparin Products Offered
    • 7.6.5 Rotexmedica GmbH Recent Development
  • 7.7 Bharat Serums and Vaccines
    • 7.7.1 Bharat Serums and Vaccines Company Information
    • 7.7.2 Bharat Serums and Vaccines Business Overview
    • 7.7.3 Bharat Serums and Vaccines Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.7.4 Bharat Serums and Vaccines Unfractionated Heparin Products Offered
    • 7.7.5 Bharat Serums and Vaccines Recent Development
  • 7.8 Troikaa Pharmaceuticals
    • 7.8.1 Troikaa Pharmaceuticals Company Information
    • 7.8.2 Troikaa Pharmaceuticals Business Overview
    • 7.8.3 Troikaa Pharmaceuticals Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.8.4 Troikaa Pharmaceuticals Unfractionated Heparin Products Offered
    • 7.8.5 Troikaa Pharmaceuticals Recent Development
  • 7.9 Wellona Pharma
    • 7.9.1 Wellona Pharma Company Information
    • 7.9.2 Wellona Pharma Business Overview
    • 7.9.3 Wellona Pharma Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.9.4 Wellona Pharma Unfractionated Heparin Products Offered
    • 7.9.5 Wellona Pharma Recent Development
  • 7.10 B. Braun
    • 7.10.1 B. Braun Company Information
    • 7.10.2 B. Braun Business Overview
    • 7.10.3 B. Braun Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.10.4 B. Braun Unfractionated Heparin Products Offered
    • 7.10.5 B. Braun Recent Development
  • 7.11 Bioiberica
    • 7.11.1 Bioiberica Company Information
    • 7.11.2 Bioiberica Business Overview
    • 7.11.3 Bioiberica Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.11.4 Bioiberica Unfractionated Heparin Products Offered
    • 7.11.5 Bioiberica Recent Development
  • 7.12 Sagent Pharmaceuticals, Inc
    • 7.12.1 Sagent Pharmaceuticals, Inc Company Information
    • 7.12.2 Sagent Pharmaceuticals, Inc Business Overview
    • 7.12.3 Sagent Pharmaceuticals, Inc Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.12.4 Sagent Pharmaceuticals, Inc Unfractionated Heparin Products Offered
    • 7.12.5 Sagent Pharmaceuticals, Inc Recent Development
  • 7.13 Gland Pharma Limited
    • 7.13.1 Gland Pharma Limited Company Information
    • 7.13.2 Gland Pharma Limited Business Overview
    • 7.13.3 Gland Pharma Limited Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.13.4 Gland Pharma Limited Unfractionated Heparin Products Offered
    • 7.13.5 Gland Pharma Limited Recent Development
  • 7.14 Stanex
    • 7.14.1 Stanex Company Information
    • 7.14.2 Stanex Business Overview
    • 7.14.3 Stanex Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.14.4 Stanex Unfractionated Heparin Products Offered
    • 7.14.5 Stanex Recent Development
  • 7.15 Mylan
    • 7.15.1 Mylan Company Information
    • 7.15.2 Mylan Business Overview
    • 7.15.3 Mylan Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.15.4 Mylan Unfractionated Heparin Products Offered
    • 7.15.5 Mylan Recent Development
  • 7.16 Rewine Pharmaceutical
    • 7.16.1 Rewine Pharmaceutical Company Information
    • 7.16.2 Rewine Pharmaceutical Business Overview
    • 7.16.3 Rewine Pharmaceutical Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.16.4 Rewine Pharmaceutical Unfractionated Heparin Products Offered
    • 7.16.5 Rewine Pharmaceutical Recent Development
  • 7.17 Jianyou Pharmaceutical
    • 7.17.1 Jianyou Pharmaceutical Company Information
    • 7.17.2 Jianyou Pharmaceutical Business Overview
    • 7.17.3 Jianyou Pharmaceutical Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.17.4 Jianyou Pharmaceutical Unfractionated Heparin Products Offered
    • 7.17.5 Jianyou Pharmaceutical Recent Development
  • 7.18 Shenzhen Techdow Pharmaceutical
    • 7.18.1 Shenzhen Techdow Pharmaceutical Company Information
    • 7.18.2 Shenzhen Techdow Pharmaceutical Business Overview
    • 7.18.3 Shenzhen Techdow Pharmaceutical Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.18.4 Shenzhen Techdow Pharmaceutical Unfractionated Heparin Products Offered
    • 7.18.5 Shenzhen Techdow Pharmaceutical Recent Development
  • 7.19 Changshan Pharma
    • 7.19.1 Changshan Pharma Company Information
    • 7.19.2 Changshan Pharma Business Overview
    • 7.19.3 Changshan Pharma Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.19.4 Changshan Pharma Unfractionated Heparin Products Offered
    • 7.19.5 Changshan Pharma Recent Development
  • 7.20 Dongcheng Pharmaceutical
    • 7.20.1 Dongcheng Pharmaceutical Company Information
    • 7.20.2 Dongcheng Pharmaceutical Business Overview
    • 7.20.3 Dongcheng Pharmaceutical Unfractionated Heparin Sales, Revenue and Gross Margin (2020-2025)
    • 7.20.4 Dongcheng Pharmaceutical Unfractionated Heparin Products Offered
    • 7.20.5 Dongcheng Pharmaceutical Recent Development

8 Unfractionated Heparin Manufacturing Cost Analysis

  • 8.1 Unfractionated Heparin Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Unfractionated Heparin
  • 8.4 Unfractionated Heparin Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Unfractionated Heparin Distributors List
  • 9.3 Unfractionated Heparin Customers

10 Unfractionated Heparin Market Dynamics

  • 10.1 Unfractionated Heparin Industry Trends
  • 10.2 Unfractionated Heparin Market Drivers
  • 10.3 Unfractionated Heparin Market Challenges
  • 10.4 Unfractionated Heparin Market Restraints

11 Research Findings and Conclusion

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Methodology/Research Approach
      • 12.1.1.1 Research Programs/Design
      • 12.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 12.1.2 Data Source
      • 12.1.2.1 Secondary Sources
      • 12.1.2.2 Primary Sources
  • 12.2 Author Details
  • 12.3 Disclaimer